Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001854270-22-000023
Filing Date
2022-08-18
Accepted
2022-08-18 16:18:25
Documents
6
Effectiveness Date
2022-08-18

Document Format Files

Seq Description Document Type Size
1 S-8 a081622s-8doc.htm S-8 82379
2 EX-FILING FEES a081622s8ex107.htm EX-FILING FEES 40409
3 EX-5.1 a081822s8ex51.htm EX-5.1 7568
4 EX-23.1 a081822s8ex231.htm EX-23.1 3475
5 EX-23.2 a081822s8ex232.htm EX-23.2 1994
6 EX-24.1 a081622s8ex241.htm EX-24.1 15180
  Complete submission text file 0001854270-22-000023.txt   152243
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266958 | Film No.: 221177693
SIC: 2836 Biological Products, (No Diagnostic Substances)